EFFECTS OF AGE AND SMOKING ON THE PHARMACOKINETICS OF PINDOLOL AND PROPRANOLOL

被引：14

作者：

HITZENBERGER, G

FITSCHA, P

BEVERIDGE, T

NUESCH, E

PACHA, W

机构：

[1] POLICLIN VIENNA,DEPT MED 2,VIENNA,AUSTRIA

[2] SANDOZ LTD,RES & DEV,CH-4002 BASEL,SWITZERLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1982年 / 13卷

关键词：

D O I：

10.1111/j.1365-2125.1982.tb01914.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：S217 / S222

页数：6

共 13 条

[1]

AELLIG WH, 1976, BR J PHARM, V3, P351

[2] PHARMACOKINETICS OF PINDOLOL IN MAN [J].

GUGLER, R ;

HEROLD, W ;

DENGLER, HJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (01) :17-24

[3] PRELIMINARY INVESTIGATIONS OF A NEW BETA-ADRENOCEPTIVE RECEPTOR BLOCKING DRUG LB46 IN MAN [J].

HILL, RC ;

TURNER, P .

BRITISH JOURNAL OF PHARMACOLOGY, 1969, 36 (02) :368-&

[4] DOSE-DEPENDENT DISPOSITION OF ORAL PROPRANOLOL IN NORMAL SUBJECTS [J].

MACKICHAN, JJ ;

PYSZCZYNSKI, DR ;

JUSKO, WJ .

BIOPHARMACEUTICS & DRUG DISPOSITION, 1980, 1 (04) :159-166

[5] PINDOLOL - PHARMACOKINETIC COMPARISON WITH OTHER BETA-ADRENOCEPTOR BLOCKING-AGENTS [J].

MEIER, J .

CURRENT MEDICAL RESEARCH AND OPINION, 1977, 4 :31-38

[6]

MEIER J, 1977, BRIT J CLIN PHARMACO, V4, P371, DOI 10.1111/j.1365-2125.1977.tb00726.x

[7] USE OF PRINDOLOL (VISKEN) IN TREATMENT OF HYPERTENSION [J].

MORGAN, TO ;

DOYLE, AE ;

LOUIS, WJ ;

DAWBORN, JK .

MEDICAL JOURNAL OF AUSTRALIA, 1972, 2 (06) :309-&

[8] HIGH-PRESSURE LIQUID-CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS QUANTITATIVE-ANALYSIS OF PROPRANOLOL AND 4-HYDROXYPROPRANOLOL IN PLASMA [J].

NATION, RL ;

PENG, GW ;

CHIOU, WL .

JOURNAL OF CHROMATOGRAPHY, 1978, 145 (03) :429-436

[9] A METHOD FOR FLUORIMETRIC DETERMINATION OF 4-(2-HYDROXY-3-ISOPROPYLAMINOPROPOXY)-INDOLE (LB46), A BETA-BLOCKING AGENT, IN PLASMA AND URINE [J].

PACHA, WL .

EXPERIENTIA, 1969, 25 (08) :802-&

[10]

Ries W, 1975, THERAPIEWOCHE, V25, P4259

← 1 2 →